Global AI Native Industry Insights – 20261113 – Anthropic | xAI | Google | more

Today’s digest features notable developments from Anthropic, xAI, and Google DeepMind. Anthropic introduces Claude Meetings, an AI assistant designed to enhance video call interactions, while xAI launches Grok Bot 1.0, which allows for more shareable and collaborative AI bot experiences. The overarching theme centers on advancing AI utility in distinct domains, from video conferencing to research collaboration. Google DeepMind’s AlphaGenome 2 emerges as a significant player with its potential in cell-specific disease research, showcasing AI’s growing role in scientific breakthroughs. The implications of these innovations point towards heightened efficiency and collaboration in both professional and research settings. Discover more in Today’s Global AI Native Industry Insights.

1. Anthropic Launches Claude Meetings, an AI Assistant for Video Calls

Anthropic has introduced Claude Meetings, a new feature that brings its Claude AI assistant into team video calls. During a live meeting, Claude can generate documents, whiteboards, and other artifacts in real time as participants talk. The feature is beginning to roll out in beta for users on Team and Enterprise plans. This positions Claude as a collaborative tool for live meeting productivity rather than only a post-call summarization assistant.
Read more: https://claude.com/resources/articles/claude-meetings

Video Credit: @claudeai on X

2. xAI Launches Grok Bot 1.0 With Shareable, More Collaborative Bots

xAI announced the release of Grok Bot 1.0, a new version of its bot feature for Grok. The update allows bots to be shared with other users. xAI says the new bots are more collaborative and more capable than previous versions. The announcement was made via the official xAI account on X.
Read more: https://x.com/SpaceXSI/status/2120584928983441826

Video Credit: @xai on X

3. Google DeepMind unveils AlphaGenome 2, an AI model for cell-specific disease research

Google DeepMind announced AlphaGenome 2, a new AI model designed to analyze how genetic variants affect specific cell types. The model aims to help scientists understand why a single DNA change can cause disease in some cells while leaving others unaffected. It builds on the earlier AlphaGenome research by zooming into cell-level genomic effects. The release targets researchers studying the genetic drivers of disease across different tissues.
Read more: https://deepmind.google/blog/alphagenome-2-deciphering-how-cells-read-dna-to-better-understand-disease/?utm_source=x&utm_medium=social&utm_campaign=&utm_content=

Video Credit: @GoogleDeepMind on X

That’s all for today’s Global AI Native Industry Insights. Join us at AI Native Foundation Membership Dashboard for the latest insights on AI Native, or follow our linkedin account at AI Native Foundation and our twitter account at AINativeF.